Investors

Overview

Neurogastrx raised $45M in equity financing in October of 2017.

Neurogastrx is a private biopharmaceutical company focused on discovering and developing transformative therapies for gastrointestinal disorders affecting the enteric nervous system.

Contact Us

52-60 Woburn, MA 01801, USA

info@neurogastrx.localhost

646-604-5150

Privacy Policy